Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
QA108
/
MingMed Biotech
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||||
||||||
QA108
/
MingMed Biotech
New P2 trial:
QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration
(clinicaltrials.gov) - Sep 30, 2022
P2
, N=120, Recruiting,
Sponsor: Smilebiotek Zhuhai Limited